Home / Generics

Generics

News

Mylan latest to recall blood pressure generics posted 31/10/2014

US generics giant Mylan has become the latest in a line of generics companies that have faced recalls of the blood pressure m...

Generics firms carve their way to victory posted 24/10/2014

US generics company Mylan has won a court battle over brand-name drugmaker Hospira, meaning it is now free to resume distribu...

Actavis agrees to continue making Alzheimer’s drug for now posted 10/10/2014

Actavis has agreed to keep selling a top Alzheimer’s disease drug for 60 days so US patients will not be forced to switch to...

New indication for old generic combination drug posted 03/10/2014

US biopharmaceutical company Avanir Pharmaceuticals has announced positive results from a phase II clinical trial of a generi...

Phase III trials for generic asthma inhaler and insulin glargine posted 03/10/2014

Generics giant Mylan is set to embark on phase III clinical trials of its generic fluticasone/salmeterol inhaler for asthma p...

 

Research

Changes to pharmaceutical policy during an economic recession posted 27/10/2014

The use of antipsychotic medicines across Finland and Portugal following the recent economic recession have been analysed in...

Reference pricing and generics in Finland posted 20/10/2014

Reference pricing and the extension of generics substitution have produced substantial savings in antipsychotic medication co...

Generics in Taiwan: urban–rural disparity posted 10/10/2014

A study of the urban–rural disparity of prescribing generic versus brand-name drugs in Taiwan has found that the generics pre...

European initiatives to enhance losartan utilization post generics: impact and implications posted 06/10/2014

Health authorities have the opportunity to realize considerable savings from generics. A wide variety of strategies were inst...

The ethics of generic immunosuppressive drugs posted 29/09/2014

A literature review of generic immunosuppressive drugs (ISDs) in renal transplant patients concludes that it is ethical to pr...

 

General

FDA names and shames firms for failing to pay generics fees posted 27/10/2014

No less than 28 generics makers are currently on the US Food and Drug Administration’s (FDA) GDUFA (Generic Drug User Fee Ame...

Canada bans imports from three API facilities in India posted 17/10/2014

Just days after Canada’s regulatory agency was reported to be in talks with the US Food and Drug Administration (FDA) about C...

Thirty years of generics in the US posted 10/10/2014

On 24 September 2014, the US Food and Drug Administration (FDA) celebrated 30 years of generics in the US.

Generics taskforce for Australia posted 26/09/2014

Australia’s Generic Medicines Industry Association (GMiA), which represents companies that manufacture, supply and export gen...

Generics applications under review by EMA – August 2014 posted 22/09/2014

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...